Share
Market Research Report

ATOPIC DERMATITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassCorticosteroids · Emollients/Moisturizers · IL-4 & PDE4 Inhibitors · Calcineurin Inhibitors Antibiotics · and Other Drug Classes
  • By Type of AdministrationTopical · Oral · and Injectable
  • By Prescription TypeOver-the-counter (OTC) and Prescription
  • Published In01 Apr 2026
  • Report CodeCMI712
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Type of Administration
      • Market Snapshot, By Prescription Type
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Rise in prevalence of atopic dermatitis worldwide
      • Adverse effects of certain therapeutic drugs
      • Increase in demand for safe/effective treatments
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Atopic Dermatitis Market, By Drug Class, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Emollients/Moisturizers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • IL-4 & PDE4 Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Calcineurin Inhibitors Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Other Drug Classes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
  5. Global Atopic Dermatitis Market, By Type of Administration, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
  6. Global Atopic Dermatitis Market, By Prescription Type, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Over-the-counter (OTC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
    • Prescription
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(US$ Mn)
  7. Global Atopic Dermatitis Market, By Geography, 2022-2033, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2022-2033,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2022-2033,(US$ Mn)
  8. Competitive Landscape

    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nestle
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LEO Pharma AS
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Encore Dermatology Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Allergan PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section

    • Research Methodology
    • About us